Bio
Janet M. Sasso earned her B.S. in Biology from The Ohio State University. She also holds her Master of Public Health from OSU where she focused her research on public health equity and education. She joined CAS in 2006 as an Information Scientist in the life sciences department curating pharmacology, pharmaceutical, environmental science, and toxicological research information. She and her team have recently studied the landscape of the gut-brain alliance in respect to mental and gastrointestinal health and disorders.
Emerging Science
Webinar: Scientific breakthroughs and emerging trends to watch in 2024
Stay ahead of the curve with insights from experts! Join our webinar featuring Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS. Discover trends like AI’s impact in R&D, biomaterials, and tackling the undruggable.
Biotechnology
How biomarkers unlock faster cancer detection, improving outcomes
Learn how biomarkers can improve cancer detection and treatment outcomes, and discover the latest research on pancreatic and liver cancer biomarkers. Read more.
Emerging Science
Biomarkers: The key to earlier cancer detection and patient outcomes
Learn how cancer biomarkers can help detect and treat cancer early. Read this report by CAS and Excelra to discover the latest advances and trends.
Drug Discovery
Unveiling the potential of the antibody drug conjugate
Learn how antibody-drug conjugates (ADCs) are transforming cancer treatment with their targeted and potent action. Discover the latest trends and developments in ADC research and development.
Emerging Science
Webinar on gut microbiome-brain alliance: The connection to health and disorders
Explore the fascinating connection between the gut microbiome and the brain in this webinar featuring experts from CAS, Bayer, and Caltech. Learn how the gut-brain axis influences health from IBS to autism and how microbiome manipulation can offer new therapeutic strategies.
Biotechnology
Webinar on nature’s lipid nanoparticles: Exosomes
Discover how exosomes, nature's lipid nanoparticles, are reshaping drug delivery and treatment of diseases from cancer to cardiovascular disease and beyond. Learn from experts at Mayo Clinic, Direct Biologics, and Aruna Bio in our recent ACS webinar. Watch the recording and read the full Insight Report now.
Drug Discovery
Exosome research: from platelet dust to pioneering therapeutics
Landscape view of emerging contributors, companies, and researchers in the emerging field of exosome research. This article overviews key players in diagnostics and therapeutic fields of exosome research with a deeper look into the current clinical pipeline.
Drug Discovery
ACS webinar on molecular glues and targeted protein degradation
Learn more about the expert panel discussion on molecular glues and targeted protein degradation. Expert panelists include Dr. Benjamin Ebert, the chair of Medical Oncology at the Dana-Farber Institute, Dr. Phil Chamberlain, the co-founder, President, and CEO of Neomorph, and Janet Sasso, an information scientist specializing in Life Sciences at CAS.
Digital R&D
The rise of AI drug development technology
"When you’re finished changing, you’re finished." Business leaders likely weren't the intended audience when Benjamin Franklin uttered his now famous quote. However, his words likely resonate deeply with leaders in today's rapidly evolving marketplace who know that for their business to thrive, they must be prepared to adapt and embrace new technologies.
Drug Discovery
Why the omicron BA.5 variant evades vaccines
As COVID-19 cases rise again worldwide, the Omicron subvariant BA.5 is currently the dominant strain. This blog explores some key mutations that increase transmission, evade protective antibodies, and increase the rate of (re)infection.
Biotechnology
Molecular glues and induced proximity: solving the undruggable
Molecular glues have been used to uncover new therapeutic agents. Because of their targeted protein degradation that holds them together, these glues have exciting potential in uncovering new drugs to fight cancer, immune diseases, and more.
Emerging Science
Monkeypox: scientifically, how worried should we be?
With recent headlines on monkeypox, learn more about the research landscape, scientific profiles, and currently available therapies. A deeper understanding of the published science enables clarity and insight on this emerging news story.
Biotechnology
A therapeutic revolution: RNA in COVID-19 and beyond
We are in the midst of a therapeutic revolution, according to the authors of a recent review article in Frontiers in Bioengineering and Biotechnology. They were commenting on the rapid expansion of RNA therapeutics in modern research and clinical development, driven in part by interest in RNA COVID-19 vaccines in the ongoing SARS-CoV-2 pandemic.
Biotechnology
COVID-19 vaccine boosters: what does the research show?
With recent mRNA booster recommendations, many ask if they should get a COVID-19 booster and what the science shows? This blog explains the science of boosters, reviews current recommendations, and examines recent research.